ArticleKidney medicine2022

Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis.

Kirk N Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.